Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.56 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.56 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.42 |
| ▸ | NOD1 | Q9Y239 | 9/20 | 0.41 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.40 |
| ▸ | GRM8 | O00222 | 1/20 | 0.38 |
| ▸ | GRM6 | O15303 | 1/20 | 0.38 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.38 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.38 |
| ▸ | GSR | P00390 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.38 |
| ▸ | GRM5 | P41594 | 1/20 | 0.38 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.38 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.38 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.38 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.38 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.38 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.38 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15668617 | 0.98 | PTGS1 (0.54) | PTGS1GSTK1GLO1NOD1FOLH1 | |
| SCHEMBL10276937 | 0.86 | PTGS1 (0.52) | PTGS1GSTK1GLO1NOD1FOLH1 | |
| SCHEMBL246687 | 0.85 | PTGS1 (0.46) | PTGS1GSTK1GLO1NOD1FOLH1 | |
| SCHEMBL5463061 | 0.84 | PTGS1 (0.61) | PTGS1GSTK1GLO1NOD1FOLH1 | |
| SCHEMBL1332934 | 0.84 | PTGS1 (0.61) | PTGS1GSTK1GLO1NOD1FOLH1 | |
| SCHEMBL365796 | 0.84 | PTGS1 (0.57) | PTGS1GSTK1GLO1NOD1FOLH1 | |
| SCHEMBL316091 | 0.83 | PTGS1 (0.60) | PTGS1GSTK1GLO1NOD1FOLH1 | |
| SCHEMBL19549046 | 0.83 | PTGS1 (0.60) | PTGS1GSTK1GLO1NOD1FOLH1 | |
| SCHEMBL4657010 | 0.82 | PTGS1 (0.56) | PTGS1GSTK1GLO1NOD1FOLH1 | |
| SCHEMBL993262 | 0.82 | PTGS1 (0.59) | PTGS1GSTK1GLO1NOD1FOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 897 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250288607-A1 | METHODS FOR TREATING SEXUAL DYSFUNCTION ASSOCIATED WITH POLYCYSTIC OVARY SYNDROME (PCOS) OR WITH HYPOACTIVE SEXUAL DESIRE DISORDER (HSDD) | Institut National de la Santé et de la Recherche Médicale (FR) | 2025-09-18 | — | — | US | claimed |
| EP-4522146-A1 | METHODS FOR TREATING SEXUAL DYSFUNCTION ASSOCIATED WITH POLYCYSTIC OVARY SYNDROME (PCOS) OR WITH HYPOACTIVE SEXUAL DESIRE DISORDER (HSDD) | Institut National de la Santé et de la Recherche Médicale (FR) | 2025-03-19 | — | — | EP | claimed |
| CN-119055582-A | Quick-dissolving microneedle patch capable of improving androgenetic alopecia and preparation method and application thereof | 西北大学 | 2024-12-03 | — | — | CN | claimed |
| WO-2024151479-A1 | CONTAINERS AND METHODS FOR NITRIC OXIDE STERILIZATION | STERILE STATE, LLC (US) | 2024-07-18 | — | — | WO | claimed |
| EP-4384272-A1 | ANTIBACTERIAL PORPHYRIN NANOPARTICLES AND METHODS FOR MAKING AND USING THE SAME | University of Georgia Research Foundation, Inc. (US) | 2024-06-19 | — | — | EP | claimed |
| CN-118021752-A | Mitochondrial targeting immunostimulation nano-drug capable of crossing blood brain barrier | 山东大学齐鲁医院 | 2024-05-14 | — | — | CN | claimed |
| US-20240091552-A1 | SYSTEMS AND METHODS FOR PHOTOTHERAPEUTIC MODULATION OF NITRIC OXIDE | FP VENTURE DEBT I BETA LTD (CY) | 2024-03-21 | — | — | US | claimed |
| WO-2024052927-A1 | NOVEL POLYMERIC FILM AND PAPER BASED PACKAGING SYSTEM TO DECELERATE SENESCENCE OF CLIMACTERIC AND NON-CLIMACTERIC HORTICULTURE PRODUCE | ORIENT PRESS LIMITED (IN) | 2024-03-14 | — | — | WO | claimed |
| US-20240041036-A1 | BIO PESTICIDAL COMPOSITION CONTAINS NOVEL NONANOATE ESTERS OF SUGARS AND SUGAR ALCOHOLS TO CONTROL LEPIDOPTERA, HEMIPTERA AND THYSANOPTERA INSECTS | FERTIS INDIA PVT. LTD. (IN) | 2024-02-08 | — | — | US | claimed |
| EP-4304717-A1 | USE OF NADOLOL TO TREAT CHRONIC OBSTRUCTIVE PULMONARY DISEASE BY BLOCKAGE OF THE ARRESTIN-2 PATHWAY | Chronic Airway Therapeutics Limited (AU) | 2024-01-17 | — | — | EP | claimed |
| WO-2001085013-A2 | INFRARED THERMOGRAPHY AND METHODS OF USE | NITROMED, INC. (US) | 2001-11-15 | — | — | WO | claimed |
| WO-2001070199-A1 | MATRICES CONTAINING NITRIC OXIDE DONORS AND REDUCING AGENTS AND THEIR USE | NOVOVASCULAR, INC. (US) | 2001-09-27 | — | — | WO | claimed |
| US-20010012834-A1 | Treating pulmonary disorders with gaseous agent causing repletion of GSNO | DUKE UNIVERSITY (US) | 2001-08-09 | — | — | US | claimed |
| WO-2001017596-A1 | METHOD OF TREATING CARDIO PULMONARY DISEASES WITH NO GROUP COMPOUNDS | DUKE UNIVERSITY (US) | 2001-03-15 | — | — | WO | claimed |
| US-6159500-A | Pharmaceutical preparations of glutathione and methods of administration thereof | ANTIOXIDANT PHARMACEUTICALS CORPORATION (US) | 2000-12-12 | — | — | US | claimed |
| EP-0957901-A1 | PHARMACEUTICAL PREPARATIONS OF GLUTATHIONE AND METHODS OF ADMINISTRATION THEREOF | Antioxidant Pharmaceuticals Corporation (US) | 1999-11-24 | — | — | EP | claimed |
| EP-0914348-A1 | POLYMERS FOR DELIVERING NITRIC OXIDE IN VIVO | DUKE UNIVERSITY MEDICAL CENTER (US) | 1999-05-12 | — | — | EP | claimed |
| WO-1998029101-A1 | PHARMACEUTICAL PREPARATIONS OF GLUTATHIONE AND METHODS OF ADMINISTRATION THEREOF | ANTIOXIDANT PHARMACEUTICALS CORPORATION (US) | 1998-07-09 | — | — | WO | claimed |
| WO-1998005689-A1 | POLYMERS FOR DELIVERING NITRIC OXIDE IN VIVO | DUKE UNIVERSITY MEDICAL CENTER (US) | 1998-02-12 | — | — | WO | claimed |
| US-5626738-A | Methods for the separation and detection of nitrosothiols | AMERICAN HEALTH FOUNDATION (US) | 1997-05-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240041036-A1 | BIO PESTICIDAL COMPOSITION CONTAINS NOVEL NONANOATE ESTERS OF SUGARS AND SUGAR ALCOHOLS TO CONTROL LEPIDOPTERA, HEMIPTERA AND THYSANOPTERA INSECTS | MGLL, ACHE, GMDS | PTGS1 2668/4885GSTK1 1661/4885GLO1 381/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.